EC Number   |
Title |
Organism |
|---|
    1.13.11.52 | 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy |
Homo sapiens |
| 1.13.11.52 | A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression |
Homo sapiens |
| 1.13.11.52 | A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors Synthesis, biological investigation and docking studies |
Homo sapiens |
| 1.13.11.52 | A novel high throughput virtual screening protocol to discover new indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors |
Homo sapiens |
| 1.13.11.52 | A single amino acid residue regulates the substrate affinity and specificity of indoleamine 2,3-dioxygenase |
Blepharisma stoltei |
| 1.13.11.52 | Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen |
Homo sapiens |
| 1.13.11.52 | Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice |
Mus musculus |
| 1.13.11.52 | Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice |
Mus musculus C57BL/6 |
| 1.13.11.52 | Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors |
Homo sapiens |
| 1.13.11.52 | Discovery and characterisation of dual inhibitors of tryptophan 2,3-dioxygenase (TDO2) and indoleamine 2,3-dioxygenase 1 (IDO1) using virtual screening |
Homo sapiens |
